-
Je něco špatně v tomto záznamu ?
Thrombotic Microangiopathy in the Renal Allograft: Results of the TMA Banff Working Group Consensus on Pathologic Diagnostic Criteria
M. Afrouzian, N. Kozakowski, H. Liapis, V. Broecker, L. Truong, C. Avila-Casado, H. Regele, S. Seshan, JM. Ambruzs, AB. Farris, D. Buob, PN. Chander, L. Cheraghvandi, MC. Clahsen-van Groningen, S. de Almeida Araujo, D. Ertoy Baydar, M. Formby, D....
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2022
PubMed Central
od 2022
Medline Complete (EBSCOhost)
od 2004-05-01
ROAD: Directory of Open Access Scholarly Resources
od 1988
PubMed
37680648
DOI
10.3389/ti.2023.11590
Knihovny.cz E-zdroje
- MeSH
- alografty MeSH
- aminy MeSH
- antikoagulancia MeSH
- konsensus MeSH
- ledviny MeSH
- lidé MeSH
- transplantace ledvin * škodlivé účinky MeSH
- trombotické mikroangiopatie * diagnóza etiologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
The Banff community summoned the TMA Banff Working Group to develop minimum diagnostic criteria (MDC) and recommendations for renal transplant TMA (Tx-TMA) diagnosis, which currently lacks standardized criteria. Using the Delphi method for consensus generation, 23 nephropathologists (panelists) with >3 years of diagnostic experience with Tx-TMA were asked to list light, immunofluorescence, and electron microscopic, clinical and laboratory criteria and differential diagnoses for Tx-TMA. Delphi was modified to include 2 validations rounds with histological evaluation of whole slide images of 37 transplant biopsies (28 TMA and 9 non-TMA). Starting with 338 criteria in R1, MDC were narrowed down to 24 in R8 generating 18 pathological, 2 clinical, 4 laboratory criteria, and 8 differential diagnoses. The panelists reached a good level of agreement (70%) on 76% of the validated cases. For the first time in Banff classification, Delphi was used to reach consensus on MDC for Tx-TMA. Phase I of the study (pathology phase) will be used as a model for Phase II (nephrology phase) for consensus regarding clinical and laboratory criteria. Eventually in Phase III (consensus of the consensus groups) and the final MDC for Tx-TMA will be reported to the transplantation community.
AeskuLab Pathology and Department of Pathology Charles University Prague Czechia
Arkana Laboratories Little Rock AR United States
Department of Anatomical Pathology NSW Health Pathology Callaghan NSW Australia
Department of Clinical Pathology Sahlgrenska University Hospital Gothenburg Sweden
Department of Nephrology Ludwig Maximilian University Munich Germany
Department of Pathology and Immunology Baylor College of Medicine Houston TX United States
Department of Pathology and Laboratory Medicine Emory University Atlanta GA United States
Department of Pathology and Laboratory Medicine Mayo Clinic Rochester MN United States
Department of Pathology and Laboratory Medicine Weill Cornell Medicine New York NY United States
Department of Pathology Istanbul Faculty of Medicine Istanbul University Istanbul Türkiye
Department of Pathology Maisonneuve Rosemont Hospital University of Montreal Montreal QC Canada
Department of Pathology Medical University of Vienna Vienna Austria
Department of Pathology Necker Enfants Malades Hospital Université Paris Cité Paris France
Department of Pathology School of Medicine Koç University Sarıyer Türkiye
Department of Pathology School of Medicine University of Zagreb Zagreb Croatia
Department of Pathology The Houston Methodist Hospital Houston TX United States
Institute of Experimental Medicine and Systems Biology RWTH Aachen University Aachen Germany
Kidney Pancreas Transplantation Instituto de Nefrología Nephrology Buenos Aires Argentina
Laboratory Medicine Program University Health Network Toronto ON Canada
New York Medical College Valhalla NY United States
School of Medicine and Public Health University of Newcastle Callaghan NSW Australia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23016517
- 003
- CZ-PrNML
- 005
- 20231026105744.0
- 007
- ta
- 008
- 231013s2023 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3389/ti.2023.11590 $2 doi
- 035 __
- $a (PubMed)37680648
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Afrouzian, Marjan $u Department of Pathology, John Sealy School of Medicine, University of Texas Medical Branch at Galveston, Galveston, TX, United States
- 245 10
- $a Thrombotic Microangiopathy in the Renal Allograft: Results of the TMA Banff Working Group Consensus on Pathologic Diagnostic Criteria / $c M. Afrouzian, N. Kozakowski, H. Liapis, V. Broecker, L. Truong, C. Avila-Casado, H. Regele, S. Seshan, JM. Ambruzs, AB. Farris, D. Buob, PN. Chander, L. Cheraghvandi, MC. Clahsen-van Groningen, S. de Almeida Araujo, D. Ertoy Baydar, M. Formby, D. Galesic Ljubanovic, L. Herrera Hernandez, E. Honsova, N. Mohamed, Y. Ozluk, M. Rabant, V. Royal, HL. Stevenson, MF. Toniolo, D. Taheri
- 520 9_
- $a The Banff community summoned the TMA Banff Working Group to develop minimum diagnostic criteria (MDC) and recommendations for renal transplant TMA (Tx-TMA) diagnosis, which currently lacks standardized criteria. Using the Delphi method for consensus generation, 23 nephropathologists (panelists) with >3 years of diagnostic experience with Tx-TMA were asked to list light, immunofluorescence, and electron microscopic, clinical and laboratory criteria and differential diagnoses for Tx-TMA. Delphi was modified to include 2 validations rounds with histological evaluation of whole slide images of 37 transplant biopsies (28 TMA and 9 non-TMA). Starting with 338 criteria in R1, MDC were narrowed down to 24 in R8 generating 18 pathological, 2 clinical, 4 laboratory criteria, and 8 differential diagnoses. The panelists reached a good level of agreement (70%) on 76% of the validated cases. For the first time in Banff classification, Delphi was used to reach consensus on MDC for Tx-TMA. Phase I of the study (pathology phase) will be used as a model for Phase II (nephrology phase) for consensus regarding clinical and laboratory criteria. Eventually in Phase III (consensus of the consensus groups) and the final MDC for Tx-TMA will be reported to the transplantation community.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a transplantace ledvin $x škodlivé účinky $7 D016030
- 650 _2
- $a konsensus $7 D032921
- 650 _2
- $a ledviny $7 D007668
- 650 12
- $a trombotické mikroangiopatie $x diagnóza $x etiologie $7 D057049
- 650 _2
- $a aminy $7 D000588
- 650 _2
- $a antikoagulancia $7 D000925
- 650 _2
- $a alografty $7 D064591
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kozakowski, Nicolas $u Department of Pathology, Medical University of Vienna, Vienna, Austria
- 700 1_
- $a Liapis, Helen $u Department of Pathology and Immunology, School of Medicine, Washington University in St. Louis, St. Louis, MO, United States $u Department of Nephrology, Ludwig Maximilian University, Munich, Germany
- 700 1_
- $a Broecker, Verena $u Department of Clinical Pathology, Sahlgrenska University Hospital, Gothenburg, Sweden
- 700 1_
- $a Truong, Luon $u Department of Pathology, The Houston Methodist Hospital, Houston, TX, United States
- 700 1_
- $a Avila-Casado, Carmen $u Laboratory Medicine Program, University Health Network (UHN), Toronto, ON, Canada
- 700 1_
- $a Regele, Heinz $u Department of Pathology, Medical University of Vienna, Vienna, Austria
- 700 1_
- $a Seshan, Surya $u Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, United States
- 700 1_
- $a Ambruzs, Josephine M $u Arkana Laboratories, Little Rock, AR, United States
- 700 1_
- $a Farris, Alton Brad $u Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, United States
- 700 1_
- $a Buob, David $u Department of Pathology, Université de Sorbonne, Assistance Publique-Hôpitaux de Paris, Hôpital Tenon, Paris, France
- 700 1_
- $a Chander, Praveen N $u New York Medical College, Valhalla, NY, United States
- 700 1_
- $a Cheraghvandi, Lukman $u Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, United States
- 700 1_
- $a Clahsen-van Groningen, Marian C $u Department of Pathology and Clinical Bioinformatics, Erasmus MC Transplant Institute, University Medical Center Rotterdam, Rotterdam, Netherlands $u Institute of Experimental Medicine and Systems Biology, RWTH Aachen University, Aachen, Germany
- 700 1_
- $a de Almeida Araujo, Stanley $u Departamento de Parasitologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
- 700 1_
- $a Ertoy Baydar, Dilek $u Department of Pathology, School of Medicine, Koç University, Sarıyer, Türkiye
- 700 1_
- $a Formby, Mark $u Department of Anatomical Pathology, NSW Health Pathology, Callaghan, NSW, Australia $u School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia
- 700 1_
- $a Galesic Ljubanovic, Danica $u Department of Pathology, School of Medicine, University of Zagreb, Zagreb, Croatia
- 700 1_
- $a Herrera Hernandez, Loren $u Department of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, MN, United States
- 700 1_
- $a Honsova, Eva $u AeskuLab Pathology and Department of Pathology, Charles University, Prague, Czechia
- 700 1_
- $a Mohamed, Nasreen $u Department of Pathology and Laboratory Medicine, King Fahad Specialist Hospital-Dammam, Dammam, Saudi Arabia
- 700 1_
- $a Ozluk, Yasemin $u Department of Pathology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Türkiye
- 700 1_
- $a Rabant, Marion $u Department of Pathology, Necker-Enfants Malades Hospital, Université Paris Cité, Paris, France
- 700 1_
- $a Royal, Virginie $u Department of Pathology, Maisonneuve-Rosemont Hospital, University of Montreal, Montreal, QC, Canada
- 700 1_
- $a Stevenson, Heather L $u Department of Pathology, John Sealy School of Medicine, University of Texas Medical Branch at Galveston, Galveston, TX, United States
- 700 1_
- $a Toniolo, Maria Fernanda $u Kidney Pancreas Transplantation, Instituto de Nefrología-Nephrology, Buenos Aires, Argentina
- 700 1_
- $a Taheri, Diana $u Department of Pathology, Isfahan Kidney Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
- 773 0_
- $w MED00004553 $t Transplant international : official journal of the European Society for Organ Transplantation $x 1432-2277 $g Roč. 36, č. - (2023), s. 11590
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37680648 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20231013 $b ABA008
- 991 __
- $a 20231026105739 $b ABA008
- 999 __
- $a ok $b bmc $g 2000184 $s 1202879
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 36 $c - $d 11590 $e 20230823 $i 1432-2277 $m Transplant international $n Transpl Int $x MED00004553
- LZP __
- $a Pubmed-20231013